U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: February 23, 2025 - March 1, 2025
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: February 23, 2025 - March 1, 2025

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Sara Brenner, M.D., M.P.H., Acting Commissioner for Food and Drugs

No Significant Event

Official Name: Kyle Diamantas, J.D., Acting Deputy Commissioner for Human Foods

No Significant Event

Official Name: Ritu Nalubola, Ph.D., Acting Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Angelique Hebert, Acting Deputy Commissioner for Operations

No Significant Event

Official Name: Michael Rogers, Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Jacqueline Corrigan Curay, J.D., M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 02/25/2025
Location: Virtual
Subject: Cell Therapies and Tissue-Based Products: A Public Workshop on Generating Scientific Evidence to Facilitate Development; Speaker: Opening Remarks
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Event Date: 02/26/2025
Location: Virtual
Subject: Center for Definitive and Curative Medicine 9th Annual Symposium; Speaker: Collaborating to Accelerate the Development of Advanced Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

Event Date: 02/25/2025
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: MATTHEW HILLEBRENNER; ELLEN FLANNERY; JOSHUA BALSAM; ANGELA KRUEGER; MARIANELA PEREZ-TORRES; OWEN FARIS; 
Non FDA Participant/Group: Ali Dianaty, Geoff Martha, Jennifer Rae, Laura Mauri, Marie Buharin, Que Dallara, Yarmela Pavlovic (Medtronic);

Event Date: 02/25/2025
Location: Silver Spring, MD
Subject: Introductory Meeting
FDA Participant/Group: ELLEN FLANNERY; SUZANNE SCHWARTZ; TAMMY BECKHAM; EDWARD MARGERRISON; KIRA MOORE; 
Non FDA Participant/Group: Alex Ferraro, Eric von Brockdorff, Mary Cordes, Matt Young, Paige Mulvaney, Todd Coomes (Chemours);

Event Date: 02/28/2025
Location: Silver Spring, MD
Subject: National Evaluation System for Health Technology 2025 Goals
FDA Participant/Group: OWEN FARIS; DANIEL CANOS; 
Non FDA Participant/Group: Andrew Fish, Simon Mason (Medical Device Innovation Consortium);

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 02/27/2025
Location: Washington, DC
Subject: General Overview of CTP
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives of the Senate appropriations staff

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Robert F. Foster, J.D., Chief Counsel

No Significant Event

Back to Top